Shares of HIMS experienced a dramatic slump today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by nearly fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts speculate